Andrew Lansdown

758 total citations
17 papers, 344 citations indexed

About

Andrew Lansdown is a scholar working on Endocrinology, Diabetes and Metabolism, Epidemiology and Surgery. According to data from OpenAlex, Andrew Lansdown has authored 17 papers receiving a total of 344 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Endocrinology, Diabetes and Metabolism, 6 papers in Epidemiology and 5 papers in Surgery. Recurrent topics in Andrew Lansdown's work include Pituitary Gland Disorders and Treatments (4 papers), Thyroid Disorders and Treatments (3 papers) and Neuroendocrine Tumor Research Advances (3 papers). Andrew Lansdown is often cited by papers focused on Pituitary Gland Disorders and Treatments (4 papers), Thyroid Disorders and Treatments (3 papers) and Neuroendocrine Tumor Research Advances (3 papers). Andrew Lansdown collaborates with scholars based in United Kingdom, Netherlands and China. Andrew Lansdown's co-authors include Aled Rees, Peter Taylor, Melanie Nana, Mark A. Atkinson, Caroline Hayhurst, John W Gregory, Lesley Lowes, John N. Harvey, D.R. Williams and J Warner and has published in prestigious journals such as The Journal of Clinical Endocrinology & Metabolism, Clinical Endocrinology and Diabetic Medicine.

In The Last Decade

Andrew Lansdown

16 papers receiving 329 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Andrew Lansdown United Kingdom	9	157	99	61	58	44	17	344
Andrea Renzullo Italy	8	153 1.0×	53 0.5×	77 1.3×	66 1.1×	47 1.1×	11	337
Muzaffer Temür Türkiye	11	126 0.8×	107 1.1×	31 0.5×	37 0.6×	74 1.7×	46	398
Marta Tenuta Italy	11	193 1.2×	94 0.9×	45 0.7×	104 1.8×	27 0.6×	26	516
Łukasz Hak Poland	10	177 1.1×	35 0.4×	81 1.3×	50 0.9×	21 0.5×	21	563
HS Randeva United Kingdom	11	78 0.5×	85 0.9×	38 0.6×	32 0.6×	45 1.0×	21	474
Germana Giannone Italy	11	167 1.1×	64 0.6×	103 1.7×	94 1.6×	27 0.6×	27	480
Vitali Gorenoi Germany	8	152 1.0×	32 0.3×	29 0.5×	69 1.2×	26 0.6×	23	367
Mikko Haanpää Finland	9	106 0.7×	68 0.7×	80 1.3×	25 0.4×	50 1.1×	13	331
Hal Landy United States	10	205 1.3×	53 0.5×	87 1.4×	26 0.4×	28 0.6×	25	384
Kanako Ogura Japan	10	40 0.3×	75 0.8×	36 0.6×	54 0.9×	46 1.0×	30	367

Countries citing papers authored by Andrew Lansdown

Since Specialization

Citations

This map shows the geographic impact of Andrew Lansdown's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Andrew Lansdown with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Andrew Lansdown more than expected).

Fields of papers citing papers by Andrew Lansdown

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Andrew Lansdown. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Andrew Lansdown. The network helps show where Andrew Lansdown may publish in the future.

Co-authorship network of co-authors of Andrew Lansdown

This figure shows the co-authorship network connecting the top 25 collaborators of Andrew Lansdown. A scholar is included among the top collaborators of Andrew Lansdown based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Andrew Lansdown. Andrew Lansdown is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

17 of 17 papers shown

Evans, Carol, Manjot K. Gill, Laura J. Parry, et al.. (2024). Current utility of first‐line FT4 and TSH in screening for central hypothyroidism. Clinical Endocrinology. 101(1). 78–84. 1 indexed citations

Taylor, Peter, Andrew Lansdown, Rahim Khan, et al.. (2023). Age-related variation in thyroid function – a narrative review highlighting important implications for research and clinical practice. Thyroid Research. 16(1). 7–7. 27 indexed citations

Lansdown, Andrew, et al.. (2023). SAT345 Disappearing Adrenal Masses: A Tale Of Two Lesions. Journal of the Endocrine Society. 7(Supplement_1).

Taylor, Peter, Andrew Lansdown, Rahim Khan, et al.. (2023). Correction to: Age-related variation in thyroid function – a narrative review highlighting important implications for research and clinical practice. Thyroid Research. 16(1). 20–20. 1 indexed citations

Atkinson, Mark A. & Andrew Lansdown. (2022). Endocrine immune-related adverse events: Adrenal, parathyroid, diabetes insipidus, and lipoatrophy. Best Practice & Research Clinical Endocrinology & Metabolism. 36(3). 101635–101635. 15 indexed citations

Nana, Melanie, et al.. (2021). Endocrine complications of immunotherapies: a review. Clinical Medicine. 21(2). e212–e222. 28 indexed citations

Ali, M. Shaaban, Andrew Lansdown, Peter Taylor, et al.. (2020). The impact of endoscopic transsphenoidal pituitary adenoma surgery on endocrine function: a single-centre study. Acta Neurochirurgica. 163(2). 391–398. 5 indexed citations

Lansdown, Andrew, et al.. (2020). Acromegaly and the information gap: patient perceptions of the journey from primary to tertiary care. Endocrine Connections. 9(10). 971–977. 3 indexed citations

Ahmad, Sajjad, et al.. (2020). Pituitary metastasis of prostate cancer presenting as a unilateral third nerve palsy. BMJ Case Reports. 13(6). e234550–e234550. 3 indexed citations

10.

Ahmad, Sajjad, et al.. (2020). Spinal epidural lipomatosis: a rare association of Cushing’s disease. Endocrinology Diabetes and Metabolism Case Reports. 2020. 9 indexed citations

11.

Hayhurst, Caroline, Peter Taylor, Andrew Lansdown, et al.. (2019). Current perspectives on recurrent pituitary adenoma: The role and timing of surgery vs adjuvant treatment. Clinical Endocrinology. 92(2). 89–97. 21 indexed citations

12.

Lansdown, Andrew, Esther A. H. Warnert, Yrsa Bergmann Sverrisdóttir, Richard G. Wise, & Aled Rees. (2019). Regional Cerebral Activation Accompanies Sympathoexcitation in Women With Polycystic Ovary Syndrome. The Journal of Clinical Endocrinology & Metabolism. 104(9). 3614–3623. 16 indexed citations

13.

Lansdown, Andrew, J Warner, D.R. Williams, et al.. (2012). Prevalence of ketoacidosis at diagnosis of childhood onset Type 1 diabetes in Wales from 1991 to 2009 and effect of a publicity campaign. Diabetic Medicine. 29(12). 1506–1509. 46 indexed citations

14.

Lansdown, Andrew & Aled Rees. (2012). The sympathetic nervous system in polycystic ovary syndrome: a novel therapeutic target?. Clinical Endocrinology. 77(6). 791–801. 124 indexed citations

15.

Chen, Shihong, et al.. (2012). An observational study of the effect of metformin on B12 status and peripheral neuropathy. The British Journal of Diabetes. 12(4). 189–193. 37 indexed citations

16.

Lansdown, Andrew & Aled Rees. (2011). Endocrine oncology in pregnancy. Best Practice & Research Clinical Endocrinology & Metabolism. 25(6). 911–926. 6 indexed citations

17.

Lansdown, Andrew, et al.. (2011). Psoas Abscess Formation in Suboptimally Controlled Diabetes Mellitus. Case Reports in Medicine. 2011. 1–3. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact